These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 591215)

  • 1. Effect of estrogen therapy on metastatic carcinoma of the prostate.
    Anikwe RM
    Int Surg; 1977 Oct; 62(10):532-6. PubMed ID: 591215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer.
    Montgomery RB; Nelson PS; Lin D; Ryan CW; Garzotto M; Beer TM
    Cancer; 2007 Sep; 110(5):996-1002. PubMed ID: 17639587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma.
    Boccon-Gibod L; Fournier G; Bottet P; Marechal JM; Guiter J; Rischman P; Hubert J; Soret JY; Mangin P; Mallo C; Fraysse CE
    Eur Urol; 1997; 32(4):391-5; discussion 395-6. PubMed ID: 9412794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ; Morales A
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine treatment of cancer of the prostate.
    Madsen PO; Pedersen JF; Knuth OE
    Wis Med J; 1970 Jul; 69(7):177-81. PubMed ID: 4916084
    [No Abstract]   [Full Text] [Related]  

  • 6. [Course of prostate cancer under estrogen therapy].
    Ducassou J; Richaud C; Hermanowicz M; Fiquet JM; Alimi JC
    J Urol Nephrol (Paris); 1977; 83(1-2):91-9. PubMed ID: 875131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prelinimary report on combination therapy for advanced prostatic cancer.
    Merrin C
    Cancer Treat Rep; 1977; 61(2):313-5. PubMed ID: 559544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of serial tissue prostate-specific antigen measurements during different hormonal treatments in prostate cancer patients.
    Grande M; Carlström K; Rozell BL; Stege R; Pousette A
    Clin Cancer Res; 2000 May; 6(5):1790-5. PubMed ID: 10815899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
    Koutsilieris M; Mitsiades CS; Bogdanos J; Dimopoulos T; Karamanolakis D; Milathianakis C; Tsintavis A
    Clin Cancer Res; 2004 Jul; 10(13):4398-405. PubMed ID: 15240528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral orchiectomy in the management of stage D-2 prostate cancer.
    Guinan P; Firfer R; Targonski P; Rubenstein M
    Int Surg; 1993; 78(1):73-5. PubMed ID: 8473090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of estrogen treatment on antithrombin III activity in patients with carcinoma of the prostate].
    Hayashi T; Takenawa J; Ryoji O; Hiura M; Taki Y; Kiriyama T
    Hinyokika Kiyo; 1989 May; 35(5):807-13. PubMed ID: 2478002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconsideration of orchiectomy in the treatment of advanced prostatic carcinoma.
    Jordan WP; Blackard CE; Byar DP
    South Med J; 1977 Dec; 70(12):1411-3. PubMed ID: 594790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis].
    Arrizabalaga Moreno M; García González JI; Mora Durvan M; Díez Rodríguez JM; Esteban Artiaga R; Navarro Sebastián J; Castro Pita M; Paniagua Andrés P
    Actas Urol Esp; 1997 Sep; 21(8):724-36. PubMed ID: 9412221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diethylstilbestrol di-trimethylacetate (DSTMA). A long-acting estrogen.
    Noland JL; Amin M
    Invest Urol; 1980 May; 17(6):506-9. PubMed ID: 7372439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinoma.
    Hellerstedt B; Pienta KJ; Redman BG; Esper P; Dunn R; Fardig J; Olson K; Smith DC
    Cancer; 2003 Oct; 98(8):1603-10. PubMed ID: 14534875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of prostate-specific antigen levels two months after hormonal manipulation of metastatic prostate cancer.
    Kawakami S; Takagi K; Yonese J; Ueda T; Fukui I; Kawai T
    Eur Urol; 1997; 32(1):58-63. PubMed ID: 9266233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience of hormone therapy to bone metastatic prostate cancer.
    Wakisaka M; Nomura K
    Int J Urol; 2006 May; 13(5):550-4. PubMed ID: 16771724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical investigation of prostate carcinoma in the Third Teaching Hospital of Norman Bethune University of Medical Sciences].
    Xiao LS; Niu FR; Xing GJ; Fu YW; Zhao LS; Liu ZY; Znang XP
    Hinyokika Kiyo; 1988 May; 34(5):814-8. PubMed ID: 3177123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of advanced prostatic carcinoma with cis-diamminedichloroplatinum].
    Okumura S; Hasegawa J; Ohhara M; Kawamura N; Abe H; Yui Y; Kanamori S; Yoshida K; Nishimura T; Tomita M
    Hinyokika Kiyo; 1984 Dec; 30(12):1801-7. PubMed ID: 6543417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis and treatment of carcinoma of the prostate with bone metastasis].
    Kawai T; Washizuka M; Yamauchi T; Ishibashi Y; Sumi S; Kokuho M
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1704-9. PubMed ID: 3592710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.